Cargando…
Matrix Metalloproteinases and Bladder Cancer: What is New?
Urothelial bladder cancer represents a heterogeneous disease with divergent pathways of tumorigenesis. Tumor invasion and progression are a multifactorial process promoted by microenvironmental changes that include overexpression of matrix metalloproteinases (MMPs). Recent data clearly challenge the...
Autores principales: | Rodriguez Faba, O., Palou-Redorta, J., Fernández-Gómez, J. M., Algaba, F., Eiró, N., Villavicencio, H., Vizoso, F. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407627/ https://www.ncbi.nlm.nih.gov/pubmed/22852097 http://dx.doi.org/10.5402/2012/581539 |
Ejemplares similares
-
Study of matrix metalloproteinases and their inhibitors in prostate cancer
por: Escaff, S, et al.
Publicado: (2010) -
Study of matrix metalloproteinases and their inhibitors in breast cancer
por: Vizoso, F J, et al.
Publicado: (2007) -
Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer
por: Eiro, Noemi, et al.
Publicado: (2023) -
Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
por: Lammers, Rianne J. M., et al.
Publicado: (2015) -
Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13
por: Sendon-Lago, Juan, et al.
Publicado: (2014)